1 / 10

Joint Academia/Industry/Government Panel Discussion

Joint Academia/Industry/Government Panel Discussion. “Current and Future Trends in Jobs for Veterinary Pathologists” Co-Chairs : Drs. Jon Werner (Amgen) and Kevin Lahmers (Washington St. Univ ) Panelists:

jacie
Download Presentation

Joint Academia/Industry/Government Panel Discussion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Joint Academia/Industry/Government Panel Discussion “Current and Future Trends in Jobs for Veterinary Pathologists” Co-Chairs: Drs. Jon Werner (Amgen) and Kevin Lahmers (Washington St. Univ) Panelists: Drs. Chris Clarke (Amgen), John Cullen (NC St Univ), Kevin Keane (Consultant), Kevin Lahmers, Charles Wood (EPA), and Aaron Sargeant (CRL)

  2. Agenda • Introduction (5 min) • Brief statements from panelists (20 min) • Please hold questions • Open discussion (35 min) • Before talking, please ID yourself • Continued discussion over cocktails

  3. Introduction Paraphrased opinion from Terry Leyden from the Leyden Group, a private recruiting firm in toxicology for over 30 years, and supporter of the ACVP/STP coalition: • Through 2008, there was a healthy job market for early career pathologists. • Since that time, this market has virtually disappeared due to: • Large and mid sized pharma reducing staff and small biotech lacking funding. • CROs having work volume drop, and sufficient staffing. • Experienced pathologists leaving industry and offering consulting services. • However, there will be a large number of experienced pathologists retiring soon - "brain drain". Companies should consider succession planning. 3

  4. Hiring in Academia Dr. John Cullen, NC State NCSU Davis/Penn • Hiring level • empty positions filled • No new positions created • Qualifications • PhD generally required • High level of competition • Lots of good diagnosticians available • Desirables • Research training/program • High level of competition • Vet Schools contracting slightly due to state funding issues • Some new positions available, but… • Need to have the right niche • Specialized diagnostic skills • Research program • Tox path depends on regional support

  5. Searching in AcademiaDr. Kevin Lahmers, Washington State • In the past year, there has been a significant uptick in jobs posted • There are a lot of people looking • Do things to help yourself stand out • Boards • PhD • Teaching experience • Specialize-to an extent • It is currently largely about fit in the current buyer’s market

  6. Hiring in industry Dr. Chris Clarke, Amgen • Qualifications – DVM, DACVP, PhD….. • DABT, MD • Experience – drug discovery and development • Discovery science – peer engagement • Tox Path – characterization, interpretation, risk assessment • Drug development projects • Technology-savvy, integrate data • Pharma CRO  academia • Management/leadership • Behaviors • Team player • “Leadership” • Problem solver, critical thinker • Proactive • Communication skills • Inquisitive • Adaptive

  7. Searching in IndustryDr. Aaron Sargeant, CRL • Flexibility • Team player with broad skills and interests • How are these influences changing pathology? - genomics, paraprofessionals, automated slide reading, 3R’s, offshoring, …

  8. Hiring in governmentDr. Charles Wood, US EPA • Widespread tightening of science/R&D budgets across federal agencies • Pressure on basic science and bench pathology roles • More emphasis on translational scientist and advisor roles • Traditional pathology skills important, bridge skills critical • Examples: Toxicology, Molecular biology/Biomarkers, Computational biology/Informatics

  9. Consulting: Various roles & skillsDr. Kevin Keane • PharmaTox. Pathology: In-depth Tox Path knowledge of a drug class or target • GLP Lab Animal Veterinarian: Team effort to have animals & facility for tox studies • Drug Program Leader: Team effort to move a novel compound to clinical trials • CRO Pathology: In-depth Tox Path knowledge of spontaneous vs. test article findings • International: Understanding how to work & teach in China & India • Society of Tox Path: Source of continuous learning and consortium building

  10. “Biomarker” of Industry Health:Net Income (losses) in NonClinical Development ($M)

More Related